Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
Clinical trial NCT03572478 · TERMINATED
Trial details
- NCT number
- NCT03572478
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-14
- Primary completion
- 2020-02-29
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.